Lenvatinib in radioiodine-refractory thyroid cancer
- PMID: 25946295
- DOI: 10.1056/NEJMc1503150
Lenvatinib in radioiodine-refractory thyroid cancer
Comment on
-
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.N Engl J Med. 2015 Feb 12;372(7):621-30. doi: 10.1056/NEJMoa1406470. N Engl J Med. 2015. PMID: 25671254 Clinical Trial.
-
Lenvatinib in radioiodine-refractory thyroid cancer.N Engl J Med. 2015 May 7;372(19):1868. doi: 10.1056/NEJMc1503150. N Engl J Med. 2015. PMID: 25946296 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical